Key takeaways
- Exhibiting at a show is the strongest signal since it reflects real, budgeted company investment; a named speaker is next, and plain attendance still gives you a timely, personal reason to propose a meeting.
- The outreach window opens before the show, once exhibitor and speaker lists go public, not after the booth closes.
- A scheduled meeting booked in advance beats a booth conversation almost every time.
- Post-show follow-up has a shelf life of a few weeks before it starts reading as a stale, generic email.
A large share of real budget conversations in life science start on a conference show floor, in partnering meetings booked weeks ahead of time, or in the hallway after a talk. Most sales teams still treat conferences as a calendar event to send a rep to, rather than as a buying-timing signal that should be showing up in the account list months before the show opens.
Why conferences are a real timing signal, not just an event
Exhibiting at a major show is not free or casual. A company commits budget and staff time to it well in advance, which is itself evidence that the company is in an active, outward-facing phase. Presenting is even more specific: a named individual, at a named company, talking about a named topic on a known date. Both are detectable from public information long before the show, which means the outreach window can open before your competitors are even thinking about the event.
The three conference signals, ranked
Timing the outreach: three windows
Before the show
This is the highest-leverage window. Exhibitor lists and speaking agendas are typically public once a show firms up its floor plan, which gives enough lead time to check company and buyer fit, identify the right contact, and propose a specific meeting time on-site or a call beforehand. A message that names the show and the reason you want to meet reads very differently from a generic cold email that happens to land the same week.
During the show
Live outreach still works, especially for contacts who post that they are attending, but it competes with a packed schedule and a full inbox. It is best used as a fallback for accounts that were not identified in time for pre-show outreach, or for genuinely last-minute opportunities.
After the show
There is a real but short follow-up window, generally measured in weeks rather than months. A message that references a specific talk or booth conversation while it is still fresh reads as attentive; the same reference well after the fact reads as a stale, generic note with an old event name bolted on.
Which shows matter for a US life science seller
The right shows depend on your buyer and your therapeutic focus, but a handful come up repeatedly across CROs, CDMOs, and life science tools and services sellers: BIO International for broad biotech business development and partnering, ASCO for oncology clinical and commercial audiences, ASH for hematology, SITC for immuno-oncology specifically, and ESMO for the European oncology audience with a strong US-company presence. Beyond the flagship shows, there is a long tail of narrower conferences, organized by modality, therapeutic area, or function (manufacturing, clinical operations, regulatory), that can matter more than a flagship show if your buyer sits in that specific niche.
Building a pre-show target list
The mechanics are straightforward in principle and tedious in practice: pull the exhibitor and speaker list for a show, cross-reference it against your account list and fit criteria, flag any matches on your side that are already tracked contacts, and prioritize outreach on whichever combination clears both the fit bar and has the strongest conference signal (exhibiting beats presenting beats attending, all else equal). See how to prioritize accounts for how that fit check should work, and which other signals to layer on top once you have the conference angle.